Evommune EVMN
NYSE EVMN
$12.41 +0.41 (+3.42%)
As of: Sep 4, 2026 · 1:32 PM EDT

Evommune (EVMN) EPS (Basic) (2024 - 2026)

Evommune (EVMN) posted quarterly EPS (Basic) of -$3.38 for Q1 2026, up 64.56% year-over-year from -$2.05 in Q1 2025, and up 26.63% quarter-over-quarter from -$4.6 in Q4 2025.

Analysis

Evommune (EVMN) EPS (Basic) (2024 - 2026) Analysis & Trends

Evommune (EVMN) has reported EPS (Basic) for 3 consecutive years, with -$3.38 the latest figure, recorded in Q1 2026.

  • In Q1 2026, EPS (Basic) rose 64.56% year-over-year to -$3.38; the TTM figure through Mar 2026 stood at -$5.02 (changed N/A YoY), while the FY2025 annual figure was -$21.55, up 51.89% from the prior year.
  • EPS (Basic) improved to -$3.38 in Q1 2026 per EVMN's latest filing, from -$4.6 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$3.38 in Q1 2026 and bottomed at -$13.75 in Q4 2024.
  • Historically, EPS (Basic) has averaged -$8.3 across 3 years, with a median of -$8.8 in 2025.
  • On a YoY basis, EPS (Basic) climbed as much as 66.53% in 2025 and fell as far as 22.85% in 2025.
  • Evommune's EPS (Basic) stood at -$13.75 in 2024, then surged by 66.53% to -$4.6 in 2025, then increased by 26.63% to -$3.38 in 2026.
  • Business Quant data shows EVMN's EPS (Basic) at -$3.38 in Q1 2026, -$4.6 in Q4 2025, and -$8.07 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.27 Bn 131.42 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 12.62
3 Argenx Se 63.45 Bn 58.27 Bn 1.37 Bn 7.70
4 Moderna 57.73 Bn 52.59 Bn 52.00 Mn -1.96
5 Revolution Medicines 44.08 Bn 44.08 Bn - -3.06
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 2.12
7 Alnylam Pharmaceuticals 35.14 Bn 31.84 Bn 992.69 Mn 1.23
8 Royalty Pharma 28.44 Bn 27.60 Bn - 0.18
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn -0.06
10 Evommune 443.38 Mn 242.59 Mn - -0.89
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.89
Mar 31, 2026 -0.64
Dec 31, 2025 -4.61
Sep 30, 2025 -8.07
Jun 30, 2025 -14.68
Mar 31, 2025 -9.40
Dec 31, 2024 -13.74
Sep 30, 2024 -10.47